Latest Clinical & Research News
To determine when additional imaging may be advisable, Hasan A. Zaidi, MD, and Blake M. Hauser of the Computational Neurosurgical Outcomes Center in the Department of Neurosurgery at Brigham and Women’s Hospital, and colleagues identified common risk factors for thoracic and lumbar spinal fractures in TBI.
Read More...
Ellen W. Seely, MD, director of clinical research in the Endocrinology, Diabetes and Hypertension Division, discusses the Brigham’s proactive approach to mitigating the impact of gestational diabetes on mothers, fetuses and newborn babies.
Read More...
Elodi Dielubanza, MD, associate surgeon in the Brigham’s Division of Urology, is seeking to normalize female urinary tract and pelvic floor disorders. She helps patients with these disorders to restore their normal daily function through surgery, medications, physical therapy and behavior modification.
Read More...
Can targeting certain brain circuits with therapeutic stimulation modulate neuropsychiatric symptoms? A recent study involving multiple Brigham and Women’s Hospital investigators including Michael D. Fox, MD, PhD, and Shan H. Siddiqi, MD, MBBS, answers that crucial question in the affirmative.
Read More...
William Henry Sauer, MD, section chief for Brigham’s Cardiac Arrhythmia Service, discusses how the hospital’s expert cardiologists are correcting heart rhythm disorders using a variety of electrophysiology-based treatments to relieve patients’ suffering, improve their quality of life and save lives.
Read More...
Brigham and Women’s Hospital investigators led by James D. Kang, MD, chair of the Department of Orthopaedic Surgery, and Shuichi Mizuno, PhD, are exploring new technology and a groundbreaking approach to slow down and even prevent intervertebral disc degeneration without resorting to surgery.
Read More...
Practice guidelines recommend considering sodium–glucose cotransporter-2 (SGLT2) inhibitors or glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for patients who have both diabetes and atherosclerotic cardiovascular disease (CVD). The choice between the drug classes is left to the physician, except that SGLT2 inhibitors are advised for patients with a history of heart failure.
Active cigarette smoking is the best-established modifiable risk factor for the development of rheumatoid arthritis (RA), but whether passive smoking can be linked to RA is unclear.
Over the past two decades, the treatment of immune-mediated inflammatory diseases (IMID) has moved from broad-spectrum immune modulators to agents that have exquisite specificity. Substantial toxicity is no longer the norm, and remission or low states of disease activity are typical outcomes.
Faculty of the Division of Rheumatology, Inflammation and Immunity at Brigham and Women’s Hospital played a prominent role at the American College of Rheumatology’s annual Convergence conference, which ran virtually from November 3 through November 10, 2021.